Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infantile spasms.

Mary L Zupanc1

  • 1Department of Neurology and Pediatrics, Division of Pediatric Neurology, Pediatric Comprehensive Epilepsy Program, MACC Fund Research Building, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. mzupanc@mcw.edu

Expert Opinion on Pharmacotherapy
|November 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical features and genotype-phenotype correlations in epilepsy patients with de novo DYNC1H1 variants.

Epilepsia·2024
Same author

Models of Transition.

Seminars in pediatric neurology·2020
Same author

PedsQL™ Cognitive Functioning Scale in youth with epilepsy: Reliability and validity.

Epilepsy & behavior : E&B·2020
Same author

Child neurology in the 21st century: More than the sum of our RVUs.

Neurology·2019
Same author

Neurocognitive Comorbidities in Pediatric Epilepsy: Lessons in the Laboratory and Clinical Profile.

Seminars in pediatric neurology·2017
Same author

Indications and methodology for video-electroencephalographic studies in the epilepsy monitoring unit.

Epilepsia·2017
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Infantile spasms, a severe infant epilepsy, often leads to developmental delays and cognitive impairment. Early treatment with adrenocorticotropin hormone (ACTH) or steroids may improve outcomes.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Developmental Neuroscience

Background:

  • Infantile spasms (IS) are a severe epilepsy syndrome affecting infants and toddlers, peaking between 4-7 months.
  • Prevalence is estimated at 1 in 2000-6000 live births, with diverse etiologies including genetic syndromes and developmental abnormalities.
  • A subset of patients present with idiopathic IS, lacking identifiable causes or prior developmental issues.

Purpose of the Study:

  • To review the causes, prognosis, and treatment of infantile spasms.
  • To highlight the challenges in managing this catastrophic epilepsy syndrome.
  • To discuss current and emerging therapeutic options.

Main Methods:

  • Literature review of infantile spasms etiology, clinical presentation, and treatment outcomes.

Related Experiment Videos

  • Analysis of the efficacy and risks of various antiepileptic drugs and hormonal therapies.
  • Discussion of surgical interventions and future therapeutic directions.

    • Main Results:

    • Infantile spasms are associated with a poor prognosis, including intractable epilepsy, severe developmental delays, and cognitive impairments in 70-90% of cases.
    • Adrenocorticotropin hormone (ACTH) or oral steroids are effective in reducing seizures and improving EEG, with earlier treatment potentially offering a better prognosis.
    • Vigabatrin, valproate, and surgical resection are other treatment options, each with specific efficacies and risks; novel therapies are under investigation.

    Conclusions:

    • Infantile spasms represent a critical neurological challenge with significant long-term consequences for affected children.
    • Aggressive and timely treatment, particularly with ACTH or steroids, is crucial for potentially altering the disease's natural history.
    • Ongoing research into molecular biology, genetics, and neuroimaging holds promise for developing more effective future therapies.